0001837412 false 0001837412 2022-08-16 2022-08-16 0001837412 SLGC:ClassCommonStock0.0001ParValuePerShareMember 2022-08-16 2022-08-16 0001837412 SLGC:WarrantsEachExercisableForOneShareOfClassCommonStockAtExercisePriceOf11.50PerShareMember 2022-08-16 2022-08-16 iso4217:USD xbrli:shares iso4217:USD xbrli:shares





Washington, D.C. 20549






Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934


 Date of Report (Date of earliest event reported): August 16, 2022


SomaLogic, Inc.

(Exact name of registrant as specified in its charter)


Delaware   001-40090   85-4298912

(State or other jurisdiction

of incorporation)

  (Commission File Number)  

(IRS Employer

Identification No.)


2945 Wilderness Place, Boulder, Colorado   80301
(Address of principal executive offices)   (Zip Code)


Registrant’s telephone number, including area code: (303) 625-9000


Not Applicable

(Former name or former address, if changed since last report)


Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation to the registrant under any of the following provisions (see General Instruction A.2 below):


Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))


Securities registered pursuant to Section 12(b) of the Act:


Title of each class   Trading Symbol(s)   Name of each exchange on which
Class A common stock, $0.0001 par value per share   SLGC   The Nasdaq Stock Market LLC
Warrants, each exercisable for one share of Class A common stock at an exercise price of $11.50 per share   SLGCW   The Nasdaq Stock Market LLC


Indicate by check mark whether the registrant is an emerging growth company as defined in as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).


Emerging growth company


If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.







Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.


On August 16, 2022, SomaLogic, Inc. (the “Company”) announced internally that Melody Harris, President and Chief Operating Officer of the Company, will be leaving the Company, effective August 31, 2022. Upon separation, Ms. Harris will receive benefits as set forth in “EXECUTIVE COMPENSATION—Executive Employment Arrangements—Enhanced Severance” in the Company’s proxy statement dated April 25, 2022. The Company’s management team and the Board of Directors would like to extend their thanks to Ms. Harris for her years of service to the Company.


Item 9.01. Financial Statements and Exhibits.


(d) Exhibits


104   Cover Page Interactive Data File







Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has caused this report to be signed on its behalf by the undersigned hereunto duly authorized.


  SomaLogic, Inc.
  By: /s/ Ruben Gutierrez
  Name:  Ruben Gutierrez
  Title: General Counsel


August 22, 2022